WP1066

WP1066 is a inhibitor of JAK2 (IC50: 2.30 μM) and STAT3 (IC50: 2.43 μM) in HEL cells; shows activity to JAK2, STAT3/5, and ERK1/2, not JAK1 and JAK3. WP1066 has been used in trials studying the treatment of Melanoma, Brain Cancer, Solid Tumors, and Central Nervous System Neoplasms.

Price Not Available 100 mg WP1066 Supplier Page

Catalog Number	T2156
Research Area	Chromatin/Epigenetic\|\|\|Stem Cells\|\|\|JAK/STAT signaling\|\|\|Angiogenesis\|\|\|Apoptosis
Molecular Formula	C17H14BrN3O
CAS#	857064-38-1
Purity	99.07%
SMILES	C[C@@H](c1ccccc1)NC(=O)/C(=C/c1nc(ccc1)Br)/C#N
Size	100 mg
Supplier Page	https://www.targetmol.com/compound/WP1066
Additional Information	https://www.targetmol.com/datasheet/T2156